Luthringer Remy
- SEC CIK
- 0001610384
No open-market purchases or sales filed in the past year.
Current role at each company
- NERV Minerva Neurosciences, Inc.CEOas of Jun 5, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Luthringer Remy as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 2, 2023 (view filing) | May 1-2 | 1 day | Luthringer RemyCEO | SSale | −27.4K | $3.84 | −$105.1K | −28.4%69.0K after | 2 lots |